Position in RGNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$330,144
+$93,309 QoQ
Shares Held
27,558
-2.5% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 163 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $333,087,992 across 79 Biotechnology names. RGNX ranks #51 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
182,365 | $90,586,166 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
86,761 | $54,098,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
69,102 | $20,801,775 | |
| 4 | INCY |
Incyte Corp
|
126,229 | $14,309,319 | |
| 5 | ARGX |
Argenx SE
|
14,868 | $13,794,084 | |
| 6 | MRNA |
Moderna, Inc.
|
152,228 | $10,660,526 | |
| 7 | RPRX |
Royalty Pharma plc
|
185,316 | $10,390,668 | |
| 8 | EXEL |
Exelixis, Inc.
|
155,922 | $8,483,716 |
All Filings in RGNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $330,144 | 27,558 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $236,835 | 28,262 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $285,854 | 19,851 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $140,021 | 14,510 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $88,988 | 10,839 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $20,842 | 2,915 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $51,396 | 6,649 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $454,720 | 43,348 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $519,386 | 44,392 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $784,035 | 37,211 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $594,773 | 33,135 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $883,062 | 53,649 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $941,868 | 47,117 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $973,902 | 51,502 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,225,876 | 54,051 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,324,301 | 50,106 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $909,058 | 36,804 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,061,615 | 31,986 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,063,927 | 32,536 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,352,506 | 32,264 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,177,698 | 30,314 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,035,988 | 30,372 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,335,534 | 29,443 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $916,746 | 33,312 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $1,421,380 | 38,593 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $1,296,883 | 40,052 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||